MA44624A - Vaccin contre le ver du c ur, procédés et utilisations associés - Google Patents

Vaccin contre le ver du c ur, procédés et utilisations associés

Info

Publication number
MA44624A
MA44624A MA044624A MA44624A MA44624A MA 44624 A MA44624 A MA 44624A MA 044624 A MA044624 A MA 044624A MA 44624 A MA44624 A MA 44624A MA 44624 A MA44624 A MA 44624A
Authority
MA
Morocco
Prior art keywords
related methods
heart worm
worm vaccine
vaccine
heart
Prior art date
Application number
MA044624A
Other languages
English (en)
Inventor
Frederic Beugnet
Laurent Fischer
Yovany Moreno
Cécile Sigoillot-Claude
Original Assignee
Merial Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Inc filed Critical Merial Inc
Publication of MA44624A publication Critical patent/MA44624A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0003—Invertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0233—Rickettsiales, e.g. Anaplasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/4354—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MA044624A 2016-04-07 2017-04-05 Vaccin contre le ver du c ur, procédés et utilisations associés MA44624A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662319731P 2016-04-07 2016-04-07
US201662423174P 2016-11-16 2016-11-16

Publications (1)

Publication Number Publication Date
MA44624A true MA44624A (fr) 2019-02-13

Family

ID=59253991

Family Applications (1)

Application Number Title Priority Date Filing Date
MA044624A MA44624A (fr) 2016-04-07 2017-04-05 Vaccin contre le ver du c ur, procédés et utilisations associés

Country Status (4)

Country Link
US (1) US10485857B2 (fr)
EP (1) EP3439690A2 (fr)
MA (1) MA44624A (fr)
WO (1) WO2017176950A2 (fr)

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2909462A (en) 1955-12-08 1959-10-20 Bristol Myers Co Acrylic acid polymer laxative compositions
EP0138854B1 (fr) 1983-03-08 1992-11-04 Chiron Mimotopes Pty. Ltd. Sequences d'acides amines antigeniquement actives
US4761281A (en) 1986-04-22 1988-08-02 Immunomed Corporation Vaccine from Dirofilaria extracts
US4842999A (en) 1986-08-11 1989-06-27 Adi Diagnostics Inc. Canine heartworm vaccine and diagnostic test
CA2123420A1 (fr) 1991-11-12 1993-05-27 Robert B. Grieve Vaccin agissant sur les proteases d'un nematode infectieux
US5492695A (en) 1992-05-14 1996-02-20 Colorado State University Research Foundation Vaccinating cats against Dirofilaria immitis with an L4 homogenate
WO1995018778A1 (fr) 1994-01-03 1995-07-13 Italtraco S.R.L. Procede de preparation d'une biomasse afin d'ameliorer la cinetique des biotransformations oxydantes a l'etat solide
US6265198B1 (en) 1994-05-26 2001-07-24 Heska Corporation Parasite astacin metalloendopeptidase proteins
US5744593A (en) 1996-02-15 1998-04-28 Heska Corporation Parasitic helminth larval thiol specific antioxidant proteins and nucleic acid molecules
EP0930893B1 (fr) 1996-10-11 2005-04-13 The Regents of The University of California Conjugues polynucleotide immunostimulateur/molecule immunomodulatrice
FR2778858B1 (fr) 1998-05-20 2000-06-16 Oreal Emulsion e/h/e stable et son utilisation comme composition cosmetique et/ou dermatologique
FR2801607B1 (fr) 1999-11-26 2001-12-28 Merial Sas Pneumovirus du canard et vaccins correspondants
SI1651265T1 (sl) 2003-07-24 2008-10-31 Merial Ltd Formulacije cepiva, ki obsegajo emulzijo olje v vodi
RU2555342C2 (ru) 2009-09-10 2015-07-10 Мериал Лимитед Новые вакцинные составы, включающие сапонинсодержащие адъюванты
EP2640417B1 (fr) 2010-11-15 2020-04-01 The Board of Trustees of the University of Illionis Vaccin multivalent pour la filariose
GB201402352D0 (en) 2014-02-11 2014-03-26 Univ Liverpool Vaccines, polypeptides, and nucleic acids

Also Published As

Publication number Publication date
EP3439690A2 (fr) 2019-02-13
US10485857B2 (en) 2019-11-26
US20170290895A1 (en) 2017-10-12
WO2017176950A2 (fr) 2017-10-12
WO2017176950A3 (fr) 2017-12-21

Similar Documents

Publication Publication Date Title
DK3209308T3 (da) Aktiverede bifidobakterier og fremgangsmåder til anvendelse deraf
DK3283106T3 (da) Terapeutiske antistoffer og anvendelser deraf
DK3271389T3 (da) Neutraliserende antistoffer mod gp120 og anvendelse deraf
DK3201351T3 (da) Kaloriefrie sødestoffer og fremgangsmåder til syntetisering
DK3142637T3 (da) Keratin treatment formulations and methods
DK3757206T3 (da) Transduktionsfremgangsmåde og cellebehandling
DK3705488T3 (da) Neuroaktive steroider, sammensætninger og anvendelse heraf
DK3215147T3 (da) Neurodæmpende norketamin-forbindelser og fremgangsmåder
DK3210977T3 (da) Hidtil ukendt aminoalkylbenzothiazepinderivat og anvendelse deraf
DK3149042T3 (da) PD-L1-antistoffer og anvendelser deraf
DK3126388T3 (da) Anti-EGFRvIII-antistoffer og anvendelser deraf
DK3155024T3 (da) Opholdsstrukturer og relaterede fremgangsmåder
DK3139979T3 (da) Enhed, forstøver og fremgangsmåde
DK3218358T3 (da) Ifluorometyl-aminopyridiner og difluorometyl-aminopyrimidiner
DK3511019T3 (da) Terapeutiske nanopartikler omfattende et terapeutisk middel og fremgangsmåder til fremstilling og anvendelse deraf
DK3368655T3 (da) Forbedret proteinekspression og fremgangsmåder dertil
DK3113797T3 (da) Antistoffer, anvendelser og fremgangsmåder
DK3095798T3 (da) Immunitetsforstærkende terapeutisk vaccine mod hpv og relaterede sygdomme
DK3334500T3 (da) Multiligand-lægemiddelskonjugater og anvendelser deraf
DK3117777T3 (da) Spredningstomografifremgangsmåde og spredningstomografianordning
DK3094640T3 (da) Fremgangsmåder til steril kromatografi og fremstilling
DK3265123T5 (da) Antistoffer, anvendelser og fremgangsmåder
DK3204085T3 (da) Hus og lægemiddeladministrationsanordning hermed
DK3164117T3 (da) Misbrugssikre formuleringer med øjeblikkelig frigivelse omfattende ikke-cellulose-polysaccharider
MA47019A (fr) Agents, utilisations et procédés